Eversept Partners
Latest statistics and disclosures from Eversept Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AMRN, UTHR, ARKG, ALXN, HZNP, and represent 31.14% of Eversept Partners's stock portfolio.
- Added to shares of these 10 stocks: ARKG (+$72M), XLRN (+$33M), CYH (+$32M), OCDX (+$27M), AMRX (+$24M), MCK (+$24M), TEVA (+$19M), BDX (+$17M), ASND (+$16M), HZNP (+$15M).
- Started 40 new stock positions in KROS, CNC, LMNX, CABA, Acadia Pharmaceuticals, Inc. C mn, IMMP, Novavax Inc call, RGEN, ARGX, Vertex Pharmaceuticals Inc option.
- Reduced shares in these 10 stocks: SRPT (-$24M), ENSG (-$17M), CTLT (-$12M), HSKA (-$11M), RAD (-$9.8M), AUPH (-$8.4M), FATE (-$6.4M), Oxford Immunotec Global (-$5.4M), NVST (-$5.2M), TGTX.
- Sold out of its positions in ALT, ANAB, AUPH, AUTL, BCRX, CATB, CNCE, KALV, ONCT, OTIC. TARA, SNY, SRPT, SESN, ZYME, Oxford Immunotec Global, MRUS.
- Eversept Partners was a net buyer of stock by $373M.
- Eversept Partners has $1.3B in assets under management (AUM), dropping by 50.23%.
- Central Index Key (CIK): 0001697013
Tip: Access up to 7 years of quarterly data
Positions held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Eversept Partners
Companies in the Eversept Partners portfolio as of the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Amarin Corp Spons Adr New (AMRN) | 8.3 | $105M | +5% | 17M | 6.21 | |
| United Therapeutics Corporation (UTHR) | 6.4 | $81M | +6% | 487k | 167.27 | |
| Ark Etf Tr Genomic Rev Etf (ARKG) | 5.7 | $72M | NEW | 807k | 88.73 | |
| Alexion Pharmaceuticals (ALXN) | 5.6 | $71M | +23% | 466k | 152.91 | |
| Horizon Therapeutics Pub L SHS (HZNP) | 5.1 | $64M | +30% | 696k | 92.04 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.0 | $50M | +58% | 4.4M | 11.54 | |
| Astrazeneca Sponsored Adr (AZN) | 3.9 | $49M | +16% | 992k | 49.72 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.2 | $40M | +66% | 312k | 128.88 | |
| Danaher Corporation (DHR) | 3.2 | $40M | +40% | 178k | 225.26 | |
| Tg Therapeutics (TGTX) | 2.9 | $37M | -11% | 763k | 48.20 | |
| Acceleron Pharma (XLRN) | 2.6 | $33M | NEW | 242k | 135.61 | |
| Community Health Systems (CYH) | 2.6 | $33M | +18688% | 2.4M | 13.52 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 2.5 | $32M | +303% | 4.8M | 6.73 | |
| Glaxosmithkline Sponsored Adr (GSK) | 2.5 | $31M | -9% | 852k | 36.44 | |
Setup an alertEversept Partners will file the next quarterly 13-HR in about 1 months. Would you like to be notified? |
||||||
| Envista Hldgs Corp (NVST) | 2.4 | $30M | -14% | 733k | 40.80 | |
| Avantor (AVTR) | 2.2 | $28M | +4% | 959k | 28.93 | |
| Ortho Clinical Diagnostics H Ord Shs (OCDX) | 2.1 | $27M | NEW | 1.4M | 19.30 | |
| Fate Therapeutics (FATE) | 2.1 | $27M | -19% | 322k | 82.45 | |
| McKesson Corporation (MCK) | 1.9 | $24M | NEW | 123k | 195.04 | |
| Anthem (ANTM) | 1.8 | $23M | -2% | 64k | 358.95 | |
| Qiagen Nv Shs New (QGEN) | 1.8 | $22M | +34% | 455k | 48.69 | |
| Glaxosmithkline Call | 1.4 | $18M | +227% | 12k | 1584.96 | |
| Catalent (CTLT) | 1.4 | $17M | -41% | 163k | 105.31 | |
| Becton, Dickinson and (BDX) | 1.3 | $17M | NEW | 68k | 243.15 | |
| Biohaven Pharmaceutical Holding (BHVN) | 1.3 | $17M | +133% | 242k | 68.35 | |
| Hca Holdings (HCA) | 1.3 | $16M | +409% | 85k | 188.34 | |
| Zogenix Com New (ZGNX) | 1.3 | $16M | -9% | 823k | 19.52 | |
| Deciphera Pharmaceuticals (DCPH) | 1.2 | $16M | +40% | 346k | 44.84 | |
| Taro Pharmaceutical Inds SHS (TARO) | 1.0 | $12M | +7% | 164k | 73.75 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $11M | NEW | 81k | 141.18 | |
| ACADIA Pharmaceuticals (ACAD) | 0.9 | $11M | NEW | 420k | 25.80 | |
| Humana (HUM) | 0.8 | $10M | NEW | 25k | 420.23 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $10M | -15% | 301k | 33.93 | |
| Argenx Se Sponsored Adr (ARGX) | 0.8 | $9.9M | NEW | 36k | 275.40 | |
| Spdr S&p 500 Etf Tr Put | 0.8 | $9.8M | NEW | 1.0k | 9844.00 | |
| Ark Etf Tr Innovation Etf (ARKK) | 0.8 | $9.8M | NEW | 82k | 119.95 | |
| Magellan Health Com New (MGLN) | 0.8 | $9.8M | 105k | 93.24 | ||
| Cigna Corp (CI) | 0.8 | $9.7M | NEW | 40k | 241.75 | |
| Mannkind Corp Com New (MNKD) | 0.7 | $8.5M | NEW | 2.2M | 3.92 | |
| Affimed Therapeutics B V (AFMD) | 0.7 | $8.3M | +8% | 1.0M | 7.91 | |
| Dex (DXCM) | 0.5 | $6.7M | +657% | 19k | 359.37 | |
| Vertex Pharmaceuticals Call | 0.5 | $6.3M | NEW | 600.00 | 10438.33 | |
| Guardant Health (GH) | 0.5 | $6.1M | NEW | 40k | 152.66 | |
| Novavax Com New (NVAX) | 0.5 | $6.1M | NEW | 34k | 181.31 | |
| Natera (NTRA) | 0.5 | $5.9M | NEW | 58k | 101.54 | |
| Centene Corporation (CNC) | 0.5 | $5.8M | NEW | 91k | 63.90 | |
| Rti Biologics (SRGA) | 0.5 | $5.8M | NEW | 2.6M | 2.18 | |
| Kadmon Hldgs (KDMN) | 0.4 | $5.3M | -42% | 1.4M | 3.89 | |
| Seres Therapeutics (MCRB) | 0.4 | $4.4M | -35% | 215k | 20.59 | |
| Luminex Corporation (LMNX) | 0.3 | $4.3M | NEW | 136k | 31.98 | |
| Immunovant (IMVT) | 0.3 | $3.7M | NEW | 230k | 16.04 | |
| Five Prime Therapeutics | 0.3 | $3.5M | -55% | 93k | 37.67 | |
| Ark Etf Tr Put | 0.2 | $3.0M | NEW | 569.00 | 5235.50 | |
| Ensign (ENSG) | 0.2 | $2.7M | -86% | 29k | 93.90 | |
| SurModics (SRDX) | 0.2 | $2.7M | +15% | 48k | 56.07 | |
| Alpha Healthcare Acquistn Cl A (AHAC) | 0.2 | $2.6M | NEW | 239k | 10.83 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $2.4M | NEW | 411k | 5.87 | |
| Agilent Technologies Inc C ommon (A) | 0.2 | $1.9M | +206% | 15k | 127.12 | |
| Intuitive Surgical Com New (ISRG) | 0.2 | $1.9M | NEW | 2.6k | 739.06 | |
| Heska Corp Com Restrc New (HSKA) | 0.1 | $1.9M | -85% | 11k | 168.48 | |
| Exagen (XGN) | 0.1 | $1.8M | +27% | 104k | 17.50 | |
| Prothena Corp SHS (PRTA) | 0.1 | $1.7M | -66% | 69k | 25.13 | |
| Keros Therapeutics (KROS) | 0.1 | $1.7M | NEW | 28k | 61.56 | |
| Intersect Ent (XENT) | 0.1 | $1.6M | NEW | 75k | 20.88 | |
| Teligent Com New (TLGT) | 0.1 | $1.6M | NEW | 2.5M | 0.62 | |
| Centene Corp Del Call | 0.1 | $1.5M | NEW | 500.00 | 3098.00 | |
| Conformis (CFMS) | 0.1 | $1.5M | NEW | 1.5M | 0.99 | |
| Frequency Therapeutics Put | 0.1 | $1.4M | NEW | 1.9k | 731.40 | |
| Liquidia Corporation Com New (LQDA) | 0.1 | $1.3M | NEW | 500k | 2.69 | |
| Iqvia Holdings (IQV) | 0.1 | $1.1M | +44% | 5.9k | 193.21 | |
| Novavax Call | 0.1 | $1.1M | NEW | 100.00 | 11160.00 | |
| Chewy Cl A (CHWY) | 0.1 | $1.1M | NEW | 13k | 84.73 | |
| Rite Aid Corporation (RAD) | 0.1 | $1.1M | -89% | 54k | 20.45 | |
| Inflarx Nv (IFRX) | 0.1 | $1.0M | NEW | 269k | 3.90 | |
| Cabaletta Bio (CABA) | 0.1 | $853k | NEW | 77k | 11.10 | |
| Gohealth Com Cl A (GOCO) | 0.1 | $805k | +132% | 69k | 11.68 | |
| Immutep Sponsored Ads (IMMP) | 0.1 | $767k | NEW | 250k | 3.07 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $554k | +238% | 13k | 42.95 | |
| Quidel Corporation (QDEL) | 0.0 | $529k | -89% | 4.1k | 128.03 | |
| Aptose Biosciences Com New (APTO) | 0.0 | $478k | NEW | 80k | 5.97 | |
| Amarin Corp Call | 0.0 | $437k | -65% | 4.4k | 99.14 | |
| Repligen Corporation (RGEN) | 0.0 | $278k | NEW | 1.4k | 194.68 | |
| Acadia Pharmaceuticals Call | 0.0 | $277k | NEW | 250.00 | 1108.00 | |
Past Filings by Eversept Partners
SEC 13F filings are viewable for Eversept Partners going back to 2017
- Eversept Partners 2021 Q1 filed May 13, 2021
- Eversept Partners 2020 Q4 filed Feb. 16, 2021
- Eversept Partners 2020 Q3 restated filed Nov. 13, 2020
- Eversept Partners 2020 Q3 filed Nov. 12, 2020
- Eversept Partners 2020 Q2 filed Aug. 13, 2020
- Eversept Partners 2020 Q1 filed May 13, 2020
- Eversept Partners 2019 Q4 filed Feb. 13, 2020
- Eversept Partners 2019 Q3 filed Nov. 13, 2019
- Eversept Partners 2019 Q2 restated filed Oct. 30, 2019
- Eversept Partners 2019 Q2 filed Aug. 13, 2019
- Eversept Partners 2019 Q1 filed May 14, 2019
- Eversept Partners 2018 Q4 filed Feb. 13, 2019
- Eversept Partners 2018 Q3 filed Nov. 14, 2018
- Eversept Partners 2018 Q2 filed Aug. 14, 2018
- Eversept Partners 2018 Q1 filed May 14, 2018
- Eversept Partners 2017 Q4 restated filed Feb. 13, 2018